Skip to main content
Low-dose-rate brachytherapy remains feasible for prostate cancer patients with median lobe hyperplasia.
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Low-dose-rate brachytherapy remains feasible for prostate cancer patients with median lobe hyperplasia.
User login
Username
Password
Reset your password
Concept
Lead
score
Prostate Cancer
1
1
Cancer
0
0.96
Bladder
0
0.16
Prostate
0
0.16
Tissue
0
0.16
Specialty
Lead
score
Hematology-Oncology
1
1
Urology
0
1